Мериоферт

Meriofert is a human-derived combination of luteinising hormone (LH) and follicle-stimulating hormone (FSH) used to support fertility treatments. This injectable therapy helps regulate ovulation in women undergoing assisted reproductive techniques. Suitable for intramuscular or subcutaneous administration.

Meriofert is used to stimulate the ovaries in women who are undergoing fertility treatments such as in vitro fertilisation (IVF) or ovulation induction. It helps produce multiple follicles to increase the chances of successful conception. This medication is typically prescribed when other methods have not been effective.

Meriofert works by mimicking the natural hormones that trigger ovulation, supporting the development of follicles in the ovaries. Patients may notice increased cervical mucus or changes in menstrual patterns as the ovaries respond to the treatment. These effects are part of the intended therapeutic action.

Meriofert should only be used under the supervision of a healthcare professional experienced in fertility treatments. Regular monitoring through blood tests and ultrasounds is necessary to avoid overstimulation of the ovaries. Patients should report any unusual symptoms, such as severe pain or swelling, immediately.

Meriofert may interact with other fertility medications, potentially increasing the risk of ovarian hyperstimulation syndrome (OHSS). Alcohol and certain herbal supplements may also affect treatment outcomes. Always inform your healthcare provider about all medications and supplements you are taking.